4//SEC Filing
Velleca Mark A. 4
Accession 0001415889-23-013339
CIK 0001701541other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:26 PM ET
Size
7.6 KB
Accession
0001415889-23-013339
Insider Transaction Report
Form 4
Velleca Mark A.
DirectorPRESIDENT & CEO
Transactions
- Award
Common Stock
2023-09-15$3.60/sh+5,208$18,749→ 46,522 total - Award
Stock Option (Right to Buy)
2023-09-17+1,000,000→ 1,000,000 totalExercise: $3.55Exp: 2033-09-16→ Common Stock (1,000,000 underlying)
Footnotes (3)
- [F1]These shares were issued in accordance with the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 14, 2023.
- [F3]25% of the shares subject to this option shall vest and become exercisable on September 17, 2024, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001706847
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:26 PM ET
- Size
- 7.6 KB